Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of SBIR/STTR awards granted to ImmuNext

List of SBIR/STTR awards granted to ImmuNext

List of SBIR/STTR awards granted to ADVANCED BRAIN MONITORING, INC.

List of SBIR/STTR awards granted to CHK GROUP, INC.

List of SBIR/STTR awards granted to Mosaic Materials

List of companies in Sp Ventures's investment portfolio

List of VSL Pharmaceuticals patents

where

SBIR/STTR Award Recipient

is

ImmuNext

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ Immunext, Inc. SBIR Phase II Award, June 2021	A SBIR Phase II contract was awarded to ImmuNext in June, 2021 for $990,946.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	ImmuNext		National Institutes of Health	SBIR	1R44AI165119-01	Phase II	990,946	June 22, 2021	sbir.gov/node/2191107
	‌ Immunext, Inc. SBIR Phase I Award, March 2018	A SBIR Phase I contract was awarded to ImmuNext in March, 2018 for $299,502.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	ImmuNext		National Institutes of Health	SBIR	1R44AI138725-01	Phase I	299,502	March 1, 2018	sbir.gov/node/1567175
	‌ Immunext, Inc. SBIR Phase II Award, August 2018	A SBIR Phase II contract was awarded to ImmuNext in August, 2018 for $1,991,930.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	ImmuNext		National Institutes of Health	SBIR	4R44AI138725-02	Phase II	1,991,930	August 15, 2018	sbir.gov/node/1572527
	‌ Immunext, Inc. SBIR Phase I Award, February 2017	A SBIR Phase I contract was awarded to ImmuNext in February, 2017 for $299,938.0 USD from the U.S. Department of Health & Human Services.	ImmuNext			SBIR	4R44AI129182-02	Phase I	299,938	February 10, 2017	sbir.gov/node/1247495
	‌ Immunext, Inc. SBIR Phase II Award, March 2013	A SBIR Phase II contract was awarded to ImmuNext in March, 2013 for $2,960,698.0 USD from the U.S. Department of Health & Human Services.	ImmuNext			SBIR	2R44AI098261-02	Phase II	2,960,698	March 1, 2013	sbir.gov/node/1031227
	‌ Immunext, Inc. SBIR Phase II Award, August 2017	A SBIR Phase II contract was awarded to ImmuNext in August, 2017 for $2,988,407.0 USD from the U.S. Department of Health & Human Services.	ImmuNext			SBIR	4R44AI129182-02	Phase II	2,988,407	August 8, 2017	sbir.gov/node/1323785
	‌ Immunext, Inc. SBIR Phase II Award, May 2016	A SBIR Phase II contract was awarded to ImmuNext in May, 2016 for $1,824,382.0 USD from the U.S. Department of Health & Human Services.	ImmuNext			SBIR	2R44AI098261-05	Phase II	1,824,382	May 20, 2016	sbir.gov/node/1164739
	‌ Immunext, Inc. STTR Phase II Award, May 2014	A STTR Phase II contract was awarded to ImmuNext in May, 2014 for $1,949,257.0 USD from the U.S. Department of Health & Human Services.	ImmuNext			STTR	2R42AI100418-03A1	Phase II	1,949,257	May 1, 2014	sbir.gov/node/1029003
	‌ Immunext, Inc. STTR Phase I Award,	A STTR Phase I contract was awarded to ImmuNext for $290,914.0 USD from the U.S. Department of Health & Human Services.	ImmuNext			STTR	1R41AI102375-01	Phase I	290,914		sbir.gov/node/676990
	‌ Immunext, Inc. STTR Phase I Award,	A STTR Phase I contract was awarded to ImmuNext for $600,000.0 USD from the U.S. Department of Health & Human Services.	ImmuNext			STTR	1R41AI100418-01	Phase I	600,000		sbir.gov/node/390933

10 results

0 selected

10 results

0 selected